To Evaluate the Tolerability and Pharmacokinetics of TQB3142 for Injection in Patients With Advanced Malignant Tumors
To Evaluate the Tolerability and Pharmacokinetics of TQB3142 for Injection in Patients With Advanced Malignant Tumors
Recruiting · NCT07338838 · Registry updated 2026-06-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| To Evaluate the Tolerability and Pharmacokinetics of TQB3142 for Injection in Patients With Advanced Malignant Tumors | Advanced Malignant Tumors | Recruiting | Phase 1 | 2026-06-23 | NCT07338838 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 88 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Guangzhou First Municipal People's Hospital | Guangzhou | China | 3 |
| Henan Cancer Hospital | Zhengzhou | China | 57 |
| Sichuan Cancer Hospital | Chengdu | China | 46 |
| The Affiliated Hospital of Southwest Medical University | Luzhou | China | 18 |
| The First Affiliated Hospital , College of Medicine, Zhejiang University | Hangzhou | China | 1 |